Fenoldopam inhibits nuclear translocation of nuclear factor kappa B in a rat model of surgical ischemic acute renal failure

被引:37
作者
Aravindan, N
Natarajan, M
Shaw, AD
机构
[1] Univ Texas, MD Anderson Canc Ctr, Div Anesthesiol & Crit Care, Houston, TX 77030 USA
[2] Univ Texas, Hlth Sci Ctr, Dept Otolaryngol Head & Neck Surg, San Antonio, TX 78285 USA
关键词
acute renal failure; fenoldopam; inflammation; ischemia/reperfusion injury; NF-kappa B; rat kidney;
D O I
10.1053/j.jvca.2005.03.028
中图分类号
R614 [麻醉学];
学科分类号
100217 ;
摘要
Objective: Vasoactive compounds are known to modulate gene transcription, including nuclear factor kappa B (NF-kappa B), in renal tissues, but the molecular effects of fenoldopam in this setting are not known. The authors used a rat model of surgical acute ischemic nephropathy to test the hypothesis that fenoldopam attenuates ischemia/reperfusion (I/R)-induced NF-kappa B-mediated inflammation. Design: Prospective, single-blind, randomized, controlled animal study. Setting: Academic Department of Anesthesiology laboratory. Subjects: Twenty-four male Sprague-Dawley rats. Interventions: Rats were anesthetized by intraperitoneal administration of 50 mg/kg of urethane and randomly allocated into 4 groups (n = 6 each): sham operation, sham operation with infusion of 0.1 mu g/kg/min of fenoldopam, unilateral renal ischemia (1 hour, left renal artery cross-clamping) followed by 4 hours of reperfusion, and unilateral renal I/R with fenoldoparn infusion. Measurements and Main Results: Kidney samples were used to measure NF-kappa B DNA-binding activity with an electrophoretic mobility shift assay. NF-kappa B signaling-dependent gene transcription was assessed with microarray analysis, and validated with reverse transcriptase polymerase chain reaction (RT-PCR). Expression of insulin-like growth factor-1 and nitric oxide synthetase-3 messenger RNA (not included in the array) was studied with RT-PCR. NF-kappa B DNA binding activity was significantly higher (p < 0.001) after I/R injury. Of the 96 genes analyzed, 75 were induced and another 8 were suppressed completely (2-fold or greater change v control) after I/R. Treatment with fenoldopam prevented activation of NF-kappa B DNA binding activity (p < 0.001) and attenuated 72 of 75 I/R-induced genes and 3 of 8 I/R-suppressed genes. Conclusion: Data from this rat model of renal I/R suggest that the mechanism by which fenoldoparn attenuates I/R-induced inflammation appears to involve inhibition of NF-kappa B translocation and signal transduction. (c) 2006 Elsevier Inc. All rights reserved.
引用
收藏
页码:179 / 186
页数:8
相关论文
共 43 条
  • [1] Pathophysiology and functional significance of apical membrane disruption during ischemia
    Ashworth, SL
    Molitoris, BA
    [J]. CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION, 1999, 8 (04) : 449 - 458
  • [2] Oxidative stress and adaptation of the infant heart to hypoxia and ischemia
    Baker, JE
    [J]. ANTIOXIDANTS & REDOX SIGNALING, 2004, 6 (02) : 423 - 429
  • [3] Selective dysregulation of nitric oxide synthase type 3 in cardiac myocytes but not coronary microvascular endothelial cells of spontaneously hypertensive rat
    Bayraktutan, U
    Yang, ZK
    Shah, AM
    [J]. CARDIOVASCULAR RESEARCH, 1998, 38 (03) : 719 - 726
  • [4] BRADY HR, 2000, ACUTE RENAL FAILURE, P1201
  • [5] The role of adhesion molecules and T cells in ischemic renal injury
    Burne-Taney, MJ
    Rabb, H
    [J]. CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION, 2003, 12 (01) : 85 - 90
  • [6] Fenoldopam for renal protection in patients undergoing cardiopulmonary bypass
    Caimmi, PP
    Pagani, L
    Micalizzi, E
    Fiume, C
    Guani, S
    Bernardi, M
    Parodi, F
    Cordero, G
    Fregonara, M
    Kapetanakis, E
    Panella, M
    De Gasperis, C
    [J]. JOURNAL OF CARDIOTHORACIC AND VASCULAR ANESTHESIA, 2003, 17 (04) : 491 - 494
  • [7] In vivo transfection of NF-κB decoy oligodeoxynucleotides attenuate renal ischemia/reperfusion injury in rats
    Cao, CC
    Ding, XQ
    Ou, ZL
    Liu, CF
    Li, P
    Wang, L
    Zhu, CF
    [J]. KIDNEY INTERNATIONAL, 2004, 65 (03) : 834 - 845
  • [8] CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2
  • [9] COSENTINO F, 1995, CLEV CLIN J MED, V62, P248
  • [10] An evaluation of pharmacological strategies for the prevention and treatment of acute renal failure
    Dishart, MK
    Kellum, JA
    [J]. DRUGS, 2000, 59 (01) : 79 - 91